XTL Biopharmaceuticals Ltd. (XTLB)
1.98
-0.01
(-0.50%)
USD |
NASDAQ |
Oct 09, 16:00
1.98
0.00 (0.00%)
After-Hours: 20:00
XTL Biopharmaceuticals Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 3.679M |
| October 08, 2026 | 3.702M |
| October 07, 2026 | 3.679M |
| October 06, 2026 | 3.774M |
| October 05, 2026 | 4.152M |
| October 02, 2026 | 4.105M |
| October 01, 2026 | 4.034M |
| September 30, 2026 | 4.436M |
| September 29, 2026 | 4.223M |
| September 28, 2026 | 4.270M |
| September 25, 2026 | 4.200M |
| September 24, 2026 | 4.696M |
| September 23, 2026 | 4.200M |
| September 22, 2026 | 4.621M |
| September 21, 2026 | 4.621M |
| September 18, 2026 | 4.672M |
| September 17, 2026 | 4.672M |
| September 16, 2026 | 4.649M |
| September 15, 2026 | 4.909M |
| September 14, 2026 | 4.743M |
| September 11, 2026 | 5.049M |
| September 10, 2026 | 4.956M |
| September 09, 2026 | 4.956M |
| September 08, 2026 | 4.98M |
| September 04, 2026 | 4.98M |
| Date | Value |
|---|---|
| September 03, 2026 | 4.909M |
| September 02, 2026 | 5.288M |
| September 01, 2026 | 4.483M |
| August 31, 2026 | 4.885M |
| August 28, 2026 | 4.838M |
| August 27, 2026 | 5.098M |
| August 26, 2026 | 5.098M |
| August 25, 2026 | 5.146M |
| August 24, 2026 | 5.205M |
| August 21, 2026 | 5.571M |
| August 20, 2026 | 5.529M |
| August 19, 2026 | 6.044M |
| August 18, 2026 | 6.636M |
| August 17, 2026 | 5.146M |
| August 14, 2026 | 5.583M |
| August 13, 2026 | 5.619M |
| August 12, 2026 | 5.358M |
| August 11, 2026 | 5.264M |
| August 10, 2026 | 5.784M |
| August 07, 2026 | 5.950M |
| August 06, 2026 | 5.784M |
| August 05, 2026 | 5.737M |
| August 04, 2026 | 5.808M |
| August 03, 2026 | 5.762M |
| July 31, 2026 | 5.666M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| BioLineRx Ltd. | 7.392M |
| Kamada Ltd. | 407.84M |
| Can-Fite BioPharma Ltd. | -4.811M |
| Eocene Ltd. | -7.716M |
| Revium Recovery, Inc. | -- |